0 out of 5 5 out of 5 4 out of 5 3 out of 5 2 out of 5 1 out of 5 Reviews Clear filters There are no reviews yet.
PlushCare Launches Enhanced Online Weight Loss Program to Expand National Access to GLP-1 Prescriptions Through Board-Certified Doctors Secure Online Access to GLP-1 Weight Loss Medications Like Semaglutide Now Available Nationwide Through PlushCare's Updated Virtual Health Platform San Francisco, June 10, 2025 (GLOBE NEWSWIRE) -- PlushCare, a leading virtual healthcare platform, has announced a significant upgrade to its online Weight Loss Program , enabling greater access to GLP-1-based prescription treatments such as semaglutide through board-certified physicians
The COST-FACIT measure assesses financial toxicity, and individual items on occupational function, social determinants of health, and caregiver availability are captured
Has your clinician reviewed the product label and these expert resources with you Potential Infant Effects and Safety Signals to Watch For Direct effects on infants from tirzepatide have not been documented, but be alert for: Feeding changes Poor weight gain Persistent vomiting Increased fussiness Signs of low blood sugar in the baby In adults, tirzepatide has been linked to nausea, vomiting, pancreatitis in rare cases, and interactions that can change the absorption of oral drugs
Your doctor may need to change the doses of your medications or monitor you carefully for side effects
